101 related articles for article (PubMed ID: 2273470)
1. Development of oral liquid dosage forms of acetazolamide.
Parasrampuria J; Das Gupta V
J Pharm Sci; 1990 Sep; 79(9):835-6. PubMed ID: 2273470
[TBL] [Abstract][Full Text] [Related]
2. Development of a stable oral liquid dosage form of spironolactone.
Pramar Y; Das Gupta V; Bethea C
J Clin Pharm Ther; 1992 Aug; 17(4):245-8. PubMed ID: 1429919
[TBL] [Abstract][Full Text] [Related]
3. Stability of acetazolamide in suspension compounded from tablets.
Alexander KS; Haribhakti RP; Parker GA
Am J Hosp Pharm; 1991 Jun; 48(6):1241-4. PubMed ID: 1858804
[TBL] [Abstract][Full Text] [Related]
4. Formulating a poorly water soluble drug into an oral solution suitable for paediatric patients; lorazepam as a model drug.
van der Vossen AC; van der Velde I; Smeets OS; Postma DJ; Eckhardt M; Vermes A; Koch BC; Vulto AG; Hanff LM
Eur J Pharm Sci; 2017 Mar; 100():205-210. PubMed ID: 28126558
[TBL] [Abstract][Full Text] [Related]
5. Stability of acetazolamide, allopurinol, azathioprine, clonazepam, and flucytosine in extemporaneously compounded oral liquids.
Allen LV; Erickson MA
Am J Health Syst Pharm; 1996 Aug; 53(16):1944-9. PubMed ID: 8862208
[TBL] [Abstract][Full Text] [Related]
6. Benzoyl peroxide solubility and stability in hydric solvents.
Chellquist EM; Gorman WG
Pharm Res; 1992 Oct; 9(10):1341-6. PubMed ID: 1448436
[TBL] [Abstract][Full Text] [Related]
7. Preformulation studies for an ultrashort-acting neuromuscular blocking agent GW280430A. I. Buffer and cosolvent effects on the solution stability.
Zhu H; Meserve K; Floyd A
Drug Dev Ind Pharm; 2002; 28(2):135-42. PubMed ID: 11926357
[TBL] [Abstract][Full Text] [Related]
8. Effect of pH, chlorobutanol, cysteine hydrochloride, ethylenediaminetetraacetic acid, propylene glycol, sodium metabisulfite, and sodium sulfite on furosemide stability in aqueous solutions.
Shah KA; Das Gupta V; Stewart KR
J Pharm Sci; 1980 May; 69(5):594-6. PubMed ID: 6770073
[TBL] [Abstract][Full Text] [Related]
9. Preformulation studies of acetazolamide: effect of pH, two buffer species, ionic strength, and temperature on its stability.
Parasrampuria J; Gupta VD
J Pharm Sci; 1989 Oct; 78(10):855-7. PubMed ID: 2600793
[TBL] [Abstract][Full Text] [Related]
10. Pediatric oral solutions with propranolol hydrochloride for extemporaneous compounding: the formulation and stability study.
Klovrzová S; Zahálka L; Matysová L; Horák P; Sklubalová Z
Ceska Slov Farm; 2013 Feb; 62(1):35-9. PubMed ID: 23578266
[TBL] [Abstract][Full Text] [Related]
11. Effect of ethanol, glycerol, and propylene glycol on the stability of phenobarbital sodium.
Das Gupta V
J Pharm Sci; 1984 Nov; 73(11):1661-2. PubMed ID: 6520779
[TBL] [Abstract][Full Text] [Related]
12. Optimization of cosolvent concentration and excipient composition in a topical corticosteroid solution.
Varia SA; Faustino MM; Thakur AB; Clow CS; Serajuddin AT
J Pharm Sci; 1991 Sep; 80(9):872-5. PubMed ID: 1800711
[TBL] [Abstract][Full Text] [Related]
13. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
Cirri M; Mura P; Mora PC
Int J Pharm; 2007 Aug; 340(1-2):84-91. PubMed ID: 17531411
[TBL] [Abstract][Full Text] [Related]
14. Nefopam hydrochloride degradation kinetics in solution.
Tu YH; Wang DP; Allen LV
J Pharm Sci; 1990 Jan; 79(1):48-52. PubMed ID: 2313576
[TBL] [Abstract][Full Text] [Related]
15. Phenobarbital stability in different dosage forms: alternatives for elixirs.
Dietz NJ; Cascella PJ; Houglum JE; Chappell GS; Sieve RM
Pharm Res; 1988 Dec; 5(12):803-5. PubMed ID: 3247290
[No Abstract] [Full Text] [Related]
16. Degradation of fenprostalene in polyethylene glycol 400 solution.
Johnson DM; Taylor WF
J Pharm Sci; 1984 Oct; 73(10):1414-7. PubMed ID: 6502492
[TBL] [Abstract][Full Text] [Related]
17. Stability of 4-DMAP in solution.
Wang DP; Chang LC; Wang MT
Drug Dev Ind Pharm; 2001 Oct; 27(9):997-1001. PubMed ID: 11763479
[TBL] [Abstract][Full Text] [Related]
18. Formulation development of allopurinol suppositories and injectables.
Lee DK; Wang DP
Drug Dev Ind Pharm; 1999 Nov; 25(11):1205-8. PubMed ID: 10596359
[TBL] [Abstract][Full Text] [Related]
19. Stability of metronidazole in solutions and suspensions.
Mathew M; Das Gupta V; Bethea C
J Clin Pharm Ther; 1994 Feb; 19(1):27-9. PubMed ID: 8188785
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical optimization of lipid-based dosage forms for the improvement of taste-masking, chemical stability and solubilizing capacity of phenobarbital.
Monteagudo E; Langenheim M; Salerno C; Buontempo F; Bregni C; Carlucci A
Drug Dev Ind Pharm; 2014 Jun; 40(6):783-92. PubMed ID: 23607724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
